COO at Regel Therapeutics
Regel Therapeutics
The startup has developed a biotechnology platform that utilizes precision gene editing techniques to create targeted gene therapies for severe and life-threatening diseases. This platform enables healthcare providers to improve patient outcomes by delivering tailored treatments for various genetic disorders.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$5.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a biotechnology platform that utilizes precision gene editing techniques to create targeted gene therapies for severe and life-threatening diseases. This platform enables healthcare providers to improve patient outcomes by delivering tailored treatments for various genetic disorders.